Exploring public perceptions of vaccine-derived poliovirus and a novel oral polio vaccine in the Democratic Republic of the Congo, Kenya, and Nigeria
Authors:
Open Access
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Vaccine hesitancy in Africa: causes and strategies to the rescueTherapeutic Advances in Vaccines and Immunotherapy, 2021
- Safety and immunogenicity of two novel type 2 oral poliovirus vaccine candidates compared with a monovalent type 2 oral poliovirus vaccine in children and infants: two clinical trialsThe Lancet, 2021
- Updated Characterization of Outbreak Response Strategies for 2019–2029: Impacts of Using a Novel Type 2 Oral Poliovirus Vaccine StrainRisk Analysis, 2020
- Certifying the interruption of wild poliovirus transmission in the WHO African region on the turbulent journey to a polio-free worldThe Lancet Global Health, 2020
- Africa declared free from wild polio — but vaccine-derived strains remainNature, 2020
- Polio endgame risks and the possibility of restarting the use of oral poliovirus vaccineExpert Review of Vaccines, 2018
- Vaccine hesitancy – a potential threat to the achievements of vaccination programmes in AfricaHuman Vaccines & Immunotherapeutics, 2018
- How Many Focus Groups Are Enough? Building an Evidence Base for Nonprobability Sample SizesField Methods, 2016
- Using the framework method for the analysis of qualitative data in multi-disciplinary health researchBMC Medical Research Methodology, 2013
- How Many Interviews Are Enough?Field Methods, 2006